SK Bioscience will also withdraw its products from the TD vaccine market that prevents diphtheria and tetanus in adults. GSK, which had been importing and supplying TD vaccines last year, also stopped supplying them in the Korean market. As a result, GC Pharma, which is manufacturing domestic drugs, is expected to strengthen its position in the TD vaccine market.

According to the MFDS on the 16th, SK Bioscience said it will stop importing SK Td Vaccine, which it is supplying, after the 18th of next month.

It said, "As the company that was supplying the undiluted solution stopped supplying the finished product, the company also stopped supplying the finished product."

Sk Td